MolNFT v1 · #90479 · protein
AKT1 with GDC0068
4EKL · Rac-alpha SERINE/THREONINE-protein kinase: “AKT1 with GDC0068”. X-ray diffraction, 1 ligand (0RF), 5 pockets (best druggability 0.77). MolNFT v1 #90479 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4EKL
- Type
- protein
- Length
- 330 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Rac-alpha SERINE/THREONINE-protein kinase
- EC
- 2.7.11.1
- UniProt
- P31749
- Ligands
- 0RF
- Pockets
- 5 · best druggability 0.77
Structure
x-ray diffraction · 1 distinct chain · 34% helix, 16% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Rac-alpha SERINE/THREONINE-protein kinase (EC 2.7.11.1) | protein | 330 | 34% helix, 16% strand | P31749 |
Ligands and binding sites
- 0RF · (2S)-2-(4-chlorophenyl)-1-{4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl}-3-(propan-2-ylamino)propan-1-one · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 444 | 0.77 | 0.85 | 44 | 0RF |
| 2 | 50 | 0.39 | 0.81 | 12 | empty |
| 3 | 95 | 0.33 | 0.73 | 15 | empty |
| 4 | 50 | 0.28 | 0.76 | 17 | empty |
| 5 | 55 | 0.27 | 0.74 | 16 | empty |
Modifications
Observed in the structure: 1 modified (phosphorylation).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P31749
- Elsewhere: RCSB PDB 4EKL · PDBe 4EKL · UniProt P31749
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.